FOXO3 and breast carcinoma: For example, neddylation inactivation by the specific inhibitor MLN4924 can prevent FOXO3 nuclear export, decrease its binding to the ESR1 (oestrogen receptor) gene promoter and improve fulvestrant sensitivity in breast cancer.